ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026
Updated Hepatitis D Seroprevalence Among Hepatitis B Surface Antigen-Positive Persons Aged ≥6 Years in the United States, National Health and Nutrition Examination Survey, 2007‒2018.
Shannon M Casillas, Asiya Chida, Jan Drobeniuc, Amy L Sandul, Saleem Kamili, Ruth B Jiles, David L Thomas, Aaron A R Tobian, Eshan U Patel, Eyasu H Teshale
Abstract read
In one paragraphArticle in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Shannon M CasillasDivision of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0001-7819-910X Asiya ChidaDivision of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-5730-1934 Jan DrobeniucDivision of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-0735-8115 Amy L SandulDivision of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-7623-8408 Saleem KamiliDivision of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Ruth B JilesDivision of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-7132-4008 David L ThomasDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-0749-925X Aaron A R TobianDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-0517-3766 Eshan U PatelDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.ORCID 0000-0003-2174-5004 Eyasu H TeshaleDivision of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0001-5244-8251 Funding
HHSIntramural CDC HHS CC999999US Centers for Disease Control and Prevention
6 · The paper itselfAbstract
To validate the accuracy of previously published US seroprevalence estimates for hepatitis D virus (HDV) antibody, we retested National Health and Nutrition Examination Survey samples from 2007 to 2018 using a different assay. We found the HDV seroprevalence among hepatitis B surface antigen-positive participants aged ≥6 years to be 1.26%.
Indexed as
Hepatitis AntibodiesHepatitis BHepatitis B Surface AntigensHepatitis DAdolescentAdultAgedChildFemaleHepatitis Delta VirusHumansMaleMiddle AgedNutrition SurveysSeroepidemiologic StudiesUnited StatesHepatitis AntibodiesHepatitis B Surface Antigenshepatitis Bhepatitis Dseroprevalence
Identifiers
PMID42033144
PMCPMC13572982
What OpenQuestion holds
Textmetadata
Read underepoch 390